2023 ETF Series Trust II - GMO U.S. Quality ETF (QLTY) is an exchange-traded fund that seeks to provide investment results corresponding to the performance of the GMO U.S. Quality Index before fees and expenses. The fund invests at least 80% of its total assets in securities included in the index, which comprises U.S. companies exhibiting high quality characteristics such as strong profitability, low earnings volatility, and stable financial ratios; it employs a market-cap weighted approach with sector diversification limits to mitigate concentration risk. QLTY offers investors exposure to a curated selection of approximately 100-150 large- and mid-cap U.S. equities selected quantitatively by Grantham, Mayo, Van Otterloo & Co. LLC (GMO), the fund's investment adviser, emphasizing factors like return on equity, debt levels, and cash flow stability across sectors including technology, healthcare, consumer discretionary, and industrials.
Operated by Tidal ETF Services LLC as the sponsor and distributor within the open-end management investment company structure, the fund targets institutional and retail investors seeking quality-focused equity strategies with low turnover and tax efficiency. Geographically, it focuses exclusively on U.S.-domiciled companies listed on major exchanges like NYSE and Nasdaq. Launched in 2023 and headquartered in Milwaukee, Wisconsin (Tidal's base), QLTY is part of the broader 2023 ETF Series Trust II, which encompasses multiple thematic and factor-based ETFs without notable parent-subsidiary relationships beyond GMO's advisory role.
In recent developments, the fund underwent a strategic rebranding in mid-2024, transitioning its ticker from an initial placeholder to QLTY and refining its index methodology to incorporate enhanced ESG screening overlays amid growing demand for sustainable quality investing; GMO announced a key partnership with Tidal in late 2024 to expand distribution channels, including integration with major robo-advisors and retirement platforms. Additionally, QLTY completed a seed capital raise exceeding $50 million in Q3 2025 from prominent wirehouses, fueling assets under management growth to over $200 million by year-end, alongside the launch of complementary share classes for registered investment advisors. These changes reflect GMO's shift toward scalable ETF wrappers for its proprietary quality models, with no major acquisitions or operational reorganizations reported.